Earnings Release: Here's Why Analysts Cut Their AbCellera Biologics Inc. (NASDAQ:ABCL) Price Target To US$12.71 [Yahoo! Finance]
AbCellera Biologics Inc. (NASDAQ: ABCL) had its price target lowered by analysts at KeyCorp from $8.00 to $7.00. They now have an "overweight" rating on the stock.
AbCellera Biologics Inc. (NASDAQ:ABCL) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
AbCellera Biologics (ABCL) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
AbCellera Biologics Inc. (ABCL) Reports Q1 Loss, Misses Revenue Estimates [Yahoo! Finance]